A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from researchers at Sinai Health in Toronto reveals that the total time it takes ...
The FDA has approved a first-of-its-kind portable, noninvasive device that delivers alternating electrical fields for the ...
FDA clears 1st treatment for pancreatic cancer in 30 years, approving Optune Pax to improve survival with chemotherapy.
Biomolecular condensates were long believed to be simple liquid blobs inside cells. Researchers have now uncovered that some are actually supported by fine protein filaments forming an internal ...
Zacks Investment Research on MSN
Novocure gains FDA approval for Optune Pax to treat pancreatic cancer
Novocure NVCR recently announced the FDA approval for its portable therapeutic device, Optune Pax, for treating adult ...
Oral cancers with a high risk of recurrence can be identified at an early stage by examining the lymphatic vessels of the tumor. Finnish researchers have discovered for the first time that the surface ...
Researchers discovered that a long-misunderstood protein plays a key role in helping chromosomes latch onto the right “tracks” during cell division. Instead of acting like a motor, it works more like ...
Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...
New findings reveal that succinate signaling through SUCNR1 acts as a protective brake in acute myeloid leukemia. Modulating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results